SEC Form 4 · accession 0001193125-26-262270
Climb Bio, Inc. · CLYM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Judith Dunn
Director
Period of report
Jun 5, 2026
Accepted (ET)
Jun 8, 2026 · 6:26 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001768446
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.55 | Jun 5, 2026 | A | 40,000 | A | — | Jun 4, 2036 | Common Stock | 40,000 | 40,000 | D |
Explanation of responses
- F1The shares subject to the option will vest on the earlier of June 5, 2027 or the date immediately prior to the date of the next annual meeting of stockholders, subject to the reporting person's continued service through such date.